Episode Details
Back to Episodes
Austria Fights Honey Fraud with DNA Tests, ImmVira Shows Promise Against Brain Cancer, Nanotechnology Targets Breast Cancer, New Blood Test Predicts Heart Disease, and more...
Published 11 months, 3 weeks ago
Description
(0:10): Austria Launches DNA Tests to Combat Honey Fraud Amid Rising EU Adulteration Concerns
(2:18): ImmVira's Oncolytic Virus Shows Promise Against Aggressive Brain Cancer in Early Trials
(4:21): Revolutionary Nanotechnology Targets Triple-Negative Breast Cancer with Precision, Reducing Side Effects
(6:30): New Blood Test Outperforms Cholesterol Checks in Predicting Heart Disease Risk
(8:51): Abpro and Celltrion Reveal Promising Results for New HER2-Targeted Cancer Therapy at AACR 2025
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Yen.com.gh
(2:18): ImmVira's Oncolytic Virus Shows Promise Against Aggressive Brain Cancer in Early Trials
(4:21): Revolutionary Nanotechnology Targets Triple-Negative Breast Cancer with Precision, Reducing Side Effects
(6:30): New Blood Test Outperforms Cholesterol Checks in Predicting Heart Disease Risk
(8:51): Abpro and Celltrion Reveal Promising Results for New HER2-Targeted Cancer Therapy at AACR 2025
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Yen.com.gh